Natriuretic peptides

Januzzi, Dr. J. L., Boston, United States International NT-proBNP consensus panel: NT-proBNP for the diagnosis of heart failure(Archiv) 04-Sep-07

Pacher, Prof. R., Vienna, Austria Clinical significance of NT-proBNP in patients with diabetes(Archiv) 04-Sep-07

Lindahl, Prof. B., Uppsala, Sweden Welcome and Introduction(Archiv) 05-Sep-06

Hildebrandt, Dr. P. R., Frederiksberg, Denmark Diagnosis of Heart Failure in the Outpatient Setting(Archiv) 05-Sep-06

Januzzi, Dr. J. L., Boston, United States Diagnosis of Heart Failure in the Emergency Department(Archiv) 05-Sep-06

Omland, Prof. T., Oslo, Norway Prognosis in a Broad Spectrum of Ischaemic Heart Disease(Archiv) 05-Sep-06

Mant, Prof. D., Oxford, United Kingdom Results from the medical research council observational pilot trial(Archiv) 02-Sep-06

Abbas, Dr. N., Kent / Canterbury, United Kingdom The relationship to renal function and left ventricular hypertrophy in chronic kidney failure(Archiv) 02-Sep-06

Hobbs, Prof. R., Birmingham, United Kingdom Natriuretic Peptides: What are the latest studies telling us?(Archiv) 02-Sep-06

Emdin, Dr. M., Pisa, Italy Improved Early Detection of Heart Failure Patients(Archiv) 19-Jun-06

Nieminen, Dr. M., Helsinki, Finland ESC Guidelines for Diagnosing Chronic and Acute Heart Failure(Archiv) 19-Jun-06

Latini, MD R., Milan, Italy Improved Prognostic Value in Heart Failure Patients(Archiv) 19-Jun-06

Filippi de, Prof. C., Maryland, United States Diagnostic and Prognostic Value in Patients with Renal Disease(Archiv) 19-Jun-06

Pacher, Prof. R., Vienna, Austria The use of NT-proBNP for the management of heart failure in out-patients(Archiv) 06-Sep-05

Bayes-Genis, Prof. A., Barcelona, Spain The use of NT-proBNP for the management of acute heart failure: diagnosis and therapy monitoring(Archiv) 06-Sep-05

Galvani, Prof. M., Forli, Italy The use of NT-proBNP for risk stratification in coronary care unit patients(Archiv) 06-Sep-05

Filippi de, Prof. C., Maryland, United States NT-proBNP: Identifying cardiovascular disease beyond heart failure and acute coronary syndrome(Archiv) 06-Sep-05

Emdin, Dr. M., Pisa, Italy NT-proBNP vs. BNP for the detection of early / mild forms of heart failure(Archiv) 10-May-05

Christenson, Dr. R. H., Maryland, United States Clinical utility of N-terminal pro B-type natriuretic peptide in patients with heart failure and acute coronary syndrome(Archiv) 10-May-05

Collinson, Dr. P. O., London, United Kingdom General and specific aspects of NTproBNP in the clinical and laboratory setting – introduction(Archiv) 10-May-05

Pieske, Prof. B., Goettingen, Germany Pro BNP in the intensive cardiac care unit(Archiv) 18-Oct-04

Maisel, Prof. A. S., San Diego, United States B-type natriuretic peptide - a marker of heart failure in diabetes?(Archiv) 03-Sep-04

Metra, Prof. M., Brescia, Italy Clinical value of monitoring N-terminal pro brain-type natriuretic peptide levels in patients with acute heart failure(Archiv) 31-Aug-04

Richards, Prof. A. M., Christchurch, New Zealand N-terminal pro brain-type natriuretic peptide in monitoring and guiding heart failure therapy(Archiv) 31-Aug-04

Lehmkuhl, Prof. H. B., Berlin, Germany N-terminal pro brain-type natriuretic peptide as a predictor of the clinical course in patients with severe heart failure(Archiv) 31-Aug-04

Lindahl, Prof. B., Uppsala, Sweden Prognostic value of N-terminal pro brain-type natriuretic peptide in patients with unstable coronary artery disease(Archiv) 31-Aug-04

Müller, Prof. C., Basel, Switzerland B-Type natriuretic peptide in the evaluation and management of acute dyspnea(Archiv) 28-Aug-04

Potapov, Dr. E., Berlin, Germany Natriuretic peptides as predictors of clinical course in patients with end-stage heart failure.(Archiv) 28-Aug-04

Wahl, Dr. H. G., Marburg, Germany Elimination of cardiac natriuretic peptides by hemodialysis(Archiv) 28-Aug-04

Price, Prof. C., London, United Kingdom The cost benefits of BNP measurement(Archiv) 28-Aug-04